Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CERTOLIZUMAB for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 19 adverse event reports in the FDA FAERS database where CERTOLIZUMAB was used for Psoriasis.

Most Reported Side Effects for CERTOLIZUMAB

Side Effect Reports % Deaths Hosp.
Drug ineffective 156 29.4% 5 48
Infection 71 13.4% 8 35
Off label use 64 12.1% 3 16
Rheumatoid arthritis 53 10.0% 2 19
Drug intolerance 51 9.6% 2 16
Arthritis 44 8.3% 0 26
Therapeutic product effect decreased 39 7.3% 1 20
Condition aggravated 36 6.8% 2 11
Treatment failure 36 6.8% 1 6
Pneumonia 35 6.6% 5 24
Psoriasis 35 6.6% 0 11
Rash 34 6.4% 7 11
Sinusitis 33 6.2% 6 10
Crohn's disease 31 5.8% 0 5
Maternal exposure during pregnancy 29 5.5% 2 10

Other Indications for CERTOLIZUMAB

Rheumatoid arthritis (158) Product used for unknown indication (137) Crohn's disease (62) Psoriatic arthropathy (45) Ankylosing spondylitis (28) Inflammatory bowel disease (19) Juvenile idiopathic arthritis (16) Malignant melanoma (10) Arthritis (9) Cogan's syndrome (8)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

CERTOLIZUMAB Full Profile All Psoriasis Drugs CERTOLIZUMAB Demographics CERTOLIZUMAB Timeline